Skip to main content

Table 2 RB1-negative frequency in clinical samples determined by the CCND1/CDKN2A expression ratio

From: Expression ratio of CCND1 to CDKN2A mRNA predicts RB1 status of cultured cancer cell lines and clinical tumor samples

Tissue

Cervical

Endometrial

SCLC

Stomach

Normal

0% (0/5)

0% (0/7)

0%

0% (0/13)

Tumor

100% (7/7)

22% (2/9)

100% (5/5)

5% (1/20)

Back to article page

Molecular Cancer

ISSN: 1476-4598